Scarica l'app Stockscreener
8.25
0.61%
0.05
Dopo l'orario di chiusura:
8.25
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ALGS Giù?
Forum
Previsione
Precedente Chiudi:
$8.20
Aprire:
$8.18
Volume 24 ore:
61,374
Relative Volume:
0.77
Capitalizzazione di mercato:
$44.15M
Reddito:
$7.97M
Utile/perdita netta:
$-75.74M
Rapporto P/E:
-0.3397
EPS:
-24.2853
Flusso di cassa netto:
$-85.33M
1 W Prestazione:
-14.82%
1M Prestazione:
-15.82%
6M Prestazione:
+47.85%
1 anno Prestazione:
-15.64%
Intervallo 1D:
$8.07
$8.76
Intervallo di 1 settimana:
$8.07
$10.06
Portata 52W:
$3.76
$46.80
Aligos Therapeutics Inc Stock (ALGS) Company Profile
Nome
Aligos Therapeutics Inc
Settore
Industria
Telefono
(800) 466-6059
Indirizzo
ONE CORPORATE DR., 2ND FLOOR, SOUTH SAN FRANCISCO
Confronta ALGS con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ALGS
Aligos Therapeutics Inc
|
8.25 | 57.00M | 7.97M | -75.74M | -85.33M | -24.29 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Aligos Therapeutics Inc Stock (ALGS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-08-18 | Ripresa | H.C. Wainwright | Buy |
| 2024-08-19 | Iniziato | H.C. Wainwright | Buy |
| 2023-01-06 | Aggiornamento | Jefferies | Hold → Buy |
| 2023-01-06 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2022-03-23 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2022-01-07 | Downgrade | JP Morgan | Overweight → Neutral |
| 2022-01-06 | Downgrade | Jefferies | Buy → Hold |
| 2021-09-09 | Iniziato | SVB Leerink | Outperform |
| 2021-05-17 | Ripresa | Piper Sandler | Overweight |
| 2020-11-10 | Iniziato | Cantor Fitzgerald | Overweight |
| 2020-11-10 | Iniziato | JP Morgan | Overweight |
| 2020-11-10 | Iniziato | Jefferies | Buy |
| 2020-11-10 | Iniziato | Piper Sandler | Overweight |
Mostra tutto
Aligos Therapeutics Inc Borsa (ALGS) Ultime notizie
How buybacks impact Aligos Therapeutics Inc. stock valueWeekly Investment Recap & Free AI Powered Buy and Sell Recommendations - newser.com
How to forecast Aligos Therapeutics Inc. trends using time seriesShort Setup & Low Drawdown Momentum Ideas - newser.com
Is Aligos Therapeutics Inc. (5WK0) stock resilient in recession scenariosTrade Entry Report & AI Enhanced Market Trend Forecasts - newser.com
How to build a dashboard for Aligos Therapeutics Inc. stockCEO Change & Daily Entry Point Alerts - newser.com
Is Aligos Therapeutics Inc. stock positioned well for digital economy2025 Major Catalysts & Free Growth Oriented Trading Recommendations - newser.com
How Aligos Therapeutics Inc. (5WK0) stock stacks up against competitors2025 Risk Factors & Growth-Oriented Investment Plans - newser.com
Multi factor analysis applied to Aligos Therapeutics Inc.Trade Analysis Report & Real-Time Volume Surge Alerts - newser.com
Why Aligos Therapeutics Inc. stock remains on buy listsJuly 2025 PostEarnings & Safe Capital Investment Plans - newser.com
Is Aligos Therapeutics Inc. stock supported by strong fundamentalsEarnings Overview Report & Precise Buy Zone Tips - newser.com
Published on: 2025-10-31 04:14:04 - newser.com
Is Aligos Therapeutics Inc. (5WK0) stock a fit for income portfoliosDollar Strength & Weekly Stock Performance Updates - newser.com
Is Aligos Therapeutics Inc. (5WK0) stock safe for risk averse investors2025 Volume Leaders & Long-Term Growth Stock Strategies - newser.com
Can Aligos Therapeutics Inc. (5WK0) stock double in coming yearsTrade Entry Report & Safe Capital Growth Plans - newser.com
Aligos Therapeutics to Announce 3rd Quarter 2025 Financial Results on November 6, 2025 - The Manila Times
Aligos Therapeutics (Nasdaq: ALGS) to announce financial results Nov 6, 2025 - Stock Titan
Aligos Therapeutics (ALGS) Expected to Announce Earnings on Wednesday - MarketBeat
Aligos Therapeutics’ Promising Hepatitis B Study: A Potential Game-Changer? - TipRanks
Aligos Therapeutics Inc Azioni (ALGS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.62%
0.21%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):